SWOT Analysis for Apyx Medical Corp

Companies with 10% increase in share price over three months, with rising net profit growth
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
Relative Outperformance versus Industry over 1 Year
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
Increasing profits every quarter for the past 4 quarters
Stock with Low PE (PE < = 10)
Volume Shockers
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter

Negative Breakdown Third Support (LTP < S3)
Momentum Trap (DVM)
Companies with High Debt
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Inefficient use of shareholder funds - ROE declining in the last 2 years
Top Losers
Negative Breakdown First Support (LTP < S1)
Negative Breakdown Second Support (LTP < S2)
Negative Breakdown third support (LTP < S3)
Companies with Increasing Debt
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years
Top Losers